Jeff Hall - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jeff Hall's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jeff Hall

Jeff Hall

Verified

Senior Editor, Diagnostic Imaging

Dresher

Final Covers

policy, drugs legislation, elections politics,marijuana cannabis, psychedelics

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 1365

  • FDA Clears Emerging Digital Tomosynthesis System

    By Jeff Hall|Diagnostic ImagingVerifiedNanox.ARC X, a multi-source digital tomosynthesis system, has garnered 510(k) clearance from the Food and Drug Administration (FDA). Adjunctive to conventional radiography, the Nanox.ARC X provides three-dimensional (3D) views for musculoskeletal and pulmonary imaging as well as intra-abdominal and paranasal sinus indications, according to Nanox, the developer of Nanox.ARC X.

    By Jeff Hall · Diagnostic Imaging

    Apr. 17, 2025

  • What is the Best Use of AI in CT Lung Cancer Screening?

    By Jeff Hall|Diagnostic ImagingVerifiedEmerging research suggests the most optimal use of artificial intelligence (AI) in low-dose computed tomography (LDCT) lung cancer screening is in pre-screening patients with radiologists only interpreting exams with positive AI findings. For the retrospective study, recently published in the American Journal of Roentgenology, researchers reviewed data for 366 people (mean age of 64) who had LDCT as part of a prior prospective lung cancer screening trial from 2017.

    By Jeff Hall · Diagnostic Imaging

    Apr. 18, 2025

  • What is the Best Use of AI in CT Lung Cancer Screening?

    By Jeff Hall|Diagnostic ImagingVerifiedEmerging research suggests the most optimal use of artificial intelligence (AI) in low-dose computed tomography (LDCT) lung cancer screening is in pre-screening patients with radiologists only interpreting exams with positive AI findings. For the retrospective study, recently published in the American Journal of Roentgenology, researchers reviewed data for 366 people (mean age of 64) who had LDCT as part of a prior prospective lung cancer screening trial from 2017.

    By Jeff Hall · Diagnostic Imaging

    Apr. 18, 2025

As seen in

Company Info

Diagnostic Imaging

The best in the region! When you need medical imaging, you deserve the best and we provide it! From CTs and MRIs, to mammograms and more, we’re centered on you.

Dresher, United States

+1 913-344-9989

Founded: 1960